Ciwujianoside B

Basic Information

View in Editor

CAS Number

114902-16-8

Molecular Formula

C58H92O25

Molecular Weight

1189.3 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

SMILES

View in Editor

CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(=C)CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)C)OC9C(C(C(CO9)O)O)OC1C(C(C(C(O1)C)O)O)O)C)O)O)O)CO)O)O)O

InChI

InChI=1S/C58H92O25/c1-23-11-16-58(53(73)83-51-44(71)40(67)37(64)30(79-51)22-75-48-45(72)41(68)46(29(20-59)78-48)81-49-42(69)38(65)34(61)24(2)76-49)18-17-56(7)26(27(58)19-23)9-10-32-55(6)14-13-33(54(4,5)31(55)12-15-57(32,56)8)80-52-47(36(63)28(60)21-74-52)82-50-43(70)39(66)35(62)25(3)77-50/h9,24-25,27-52,59-72H,1,10-22H2,2-8H3/t24-,25-,27-,28-,29+,30+,31-,32+,33-,34-,35-,36-,37+,38+,39+,40-,41+,42+,43+,44+,45+,46+,47+,48+,49-,50-,51-,52-,55-,56+,57+,58-/m0/s1

InChIKey

UPROOJBJZLZCGS-CHTHVDMYSA-N

LogP

-1.986799999999985

Topological Polar Surface Area

392.5900000000001 Å²

Hydrogen Bond Donor/Acceptor

14 / 25

Complexity

2350

Synonyms & References

English

ciwujianoside B
MS-32037
Q-100073
BDBM50253018
Ciwujianoside-B
CHEMBL3890430
Yemuoside YM(10)
AKOS040753101
yemuoside YM
114902-16-8
Yemuoside YM10
28-O-Rhamnopyranosyl-(1-4)-glucopyranosyl-(1-6)-glucopyranosyl 3-O-rhamnosyl-(1-2)-arabinopyranosyl-30-norolean-12,20(29)-dien-28-oic acid
Ciwujianoside B; Acanthopanax senticosides B
30-Noroleana-12,20(29)-dien-28-oic acid, 3-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl)oxy)-, O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl ester, (3beta)-
Acanthopanax senticosides B
CS-0008805
HY-N0307
SCHEMBL17187835
Ciwujianoside B
30-Noroleana-12,20(29)-dien-28-oicacid, 3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-a-L-arabinopyranosyl]oxy]-, O-6-deoxy-a-L-mannop
30-Noroleana-12,20(29)-dien-28-oicacid, 3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-a-L-arabinopyranosyl]oxy]-, O-6-deoxy-a-L-mannopyranosyl-(1&reg
CIWUJIANOSIDE B (RG)
yemuoside YM(10)
4)-O-b-D-glucopyranosyl-(1&reg
6)-b-D-glucopyranosyl ester, (3b)-
acanthopanax senticosides B
yemuoside YM10

MDL Number

MFCD10566605

FAQ

What regulatory guidelines apply to Ciwujianoside B (CAS: 114902-16-8)?

Ciwujianoside B (CAS: 114902-16-8) falls under the classification of a secondary metabolite. Regulatory guidelines include the Chemicals Registration Regulation (EC) No 1907/2006 (REACH) for its manufacturing and import in Europe, and the U.S. EPA's Toxic Substance Control Act (TSCA) for its use and import in the U.S. Additionally, it should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for proper labeling and handling.

Are there alternatives to Ciwujianoside B (CAS: 114902-16-8) in synthesis?

In the synthesis of natural products like Ciwujianoside B (CAS: 114902-16-8), alternatives include using similar triterpene derivatives such as ursolic acid and oleanolic acid. Isomers and analogs of Ciwujianoside B can also serve as useful alternatives, and researchers often explore the use of biocatalysis and green chemistry approaches to produce these compounds more sustainably.

What is the market or research trend for Ciwujianoside B (CAS: 114902-16-8)?

The market for Ciwujianoside B (CAS: 114902-16-8) is driven by its potential in traditional Chinese medicine and as a potential therapeutic agent. Research trends focus on its antioxidant, anti-inflammatory, and anti-tumor properties. Recent studies are exploring its use in pharmaceuticals and cosmetics. Market trends indicate increasing interest in natural products for their health benefits, leading to a growing demand for Ciwujianoside B and similar compounds.

How should waste containing Ciwujianoside B (CAS: 114902-16-8) be handled?

Waste containing Ciwujianoside B (CAS: 114902-16-8) should be managed according to local and international hazardous waste regulations. Proper collection methods include using compatible containers to prevent leakage. Incineration is a common disposal method, but it must comply with environmental regulations. For specialized handling, consult with a hazardous waste management company. Always ensure that waste disposal follows the principles of minimizing environmental impact and safety.